1. Home
  2. SIBN vs VALN Comparison

SIBN vs VALN Comparison

Compare SIBN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$20.36

Market Cap

883.4M

Sector

Health Care

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$8.47

Market Cap

820.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIBN
VALN
Founded
2008
2012
Country
United States
France
Employees
349
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
883.4M
820.0M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
SIBN
VALN
Price
$20.36
$8.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$25.57
$15.75
AVG Volume (30 Days)
486.6K
24.4K
Earning Date
11-10-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,578,000.00
$211,089,992.00
Revenue This Year
$21.44
$5.08
Revenue Next Year
$15.30
$12.53
P/E Ratio
N/A
N/A
Revenue Growth
23.27
13.48
52 Week Low
$12.50
$4.02
52 Week High
$21.07
$12.25

Technical Indicators

Market Signals
Indicator
SIBN
VALN
Relative Strength Index (RSI) 63.98 45.38
Support Level $18.34 $8.26
Resistance Level $21.07 $8.64
Average True Range (ATR) 0.73 0.28
MACD 0.04 -0.00
Stochastic Oscillator 73.99 40.09

Price Performance

Historical Comparison
SIBN
VALN

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: